Clinical Trials Logo

Filter by:
NCT ID: NCT01103648 Completed - Inflammation Clinical Trials

Effect of Simvastatin and Ezetimibe on Lipid and Inflammation

Start date: June 2005
Phase: N/A
Study type: Interventional

Ezetimibe specifically blocks the absorption of dietary and biliary cholesterol and plant sterols. Synergism of ezetimibe-statin therapy on LDL-cholesterol has been demonstrated, but data concerning the pleiotropic effects of this combination are controversial. We tested the hypothesis that the combination of simvastatin and ezetimibe would induce improvement in inflammatory status, as reflected by leukocyte count and CRP, IL-6 and TNF-a levels. This open-label trial evaluated whether this combination results in a synergistic effect the pro-inflammatory status of pre-diabetic subjects. Fifty pre-diabetic subjects were randomly assigned to one of 2 groups, one receiving ezetimibe (10 mg/d), the other, simvastatin (20 mg/d) for 12 weeks, followed by an additional 12-week period of combined therapy.

NCT ID: NCT01103323 Completed - Clinical trials for Metastatic Colorectal Cancer

Patients With Metastatic Colorectal Cancer Treated With Regorafenib or Placebo After Failure of Standard Therapy

Start date: April 2010
Phase: Phase 3
Study type: Interventional

This is a randomized, double-blind, placebo-controlled multi-center phase III study to evaluate efficacy and safety of regorafenib in patients with metastatic colorectal cancer (CRC) who have progressed on/after all approved drugs for CRC

NCT ID: NCT01102946 Completed - Clinical trials for Diabetic Retinopathy

Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy

IRaHi
Start date: February 2009
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of panretinal photocoagulation plus intravitreal ranibizumab for the treatment of patients with high risk proliferative diabetic retinopathy in terms of changes in visual acuity and neovascularization area.

NCT ID: NCT01102621 Completed - Hearing Loss Clinical Trials

Hearing Loss and Complaint in Patients With Head and Neck Cancer Treated With Radiotherapy

Start date: January 2005
Phase: N/A
Study type: Observational

Hypothesis: Treatment for head and neck tumors often involve methods that affect the auditory system and cause hearing loss. Neck dissection negatively impacts the lymphatic drainage, chemotherapy uses ototoxic drugs, radiotherapy affects blood flow and tissue radiation is toxic to the ear and may lead to hearing losses of various types and degrees. Objective: To investigate occurrences of hearing loss and complaints among patients with head and neck tumors who underwent radiotherapy. Study design: Prospective, case-control study. Setting: Tertiary care center hospital. Subjects and Methods: 282 subjects were evaluated, 141 with head and neck tumors and 141 as an age-matched control group. The controls had never undergone oncological treatment that put their hearing at risk. All subjects underwent audiological evaluation, including the HHIE questionnaire, pure tone audiometry, speech audiometry and immittance audiometry. The radiation dose received by the auditory system was calculated based on the percentage of the external auditory canal included in the radiation field.

NCT ID: NCT01100541 Completed - Thermotherapy Clinical Trials

Evaluation of a Polymeric Plate Derived From Castor Oil to Thermotherapy

Start date: February 2010
Phase: N/A
Study type: Interventional

The objective of this work is to evaluate, from volunteers viewpoint, the usability, comfort, appearance, weight, superficial temperature, and other characteristics of a polymeric plate derived from castor oil developed to thermotherapy. The volunteers will use polymeric plate as a therapeutic resource in the shoulder area and then fill in, without interference of the researcher, some questions about the characteristics of interest.

NCT ID: NCT01100164 Completed - INSOMNIA Clinical Trials

A Non-inferiority Study With Two Treatment Arms Eszopiclone 3 mg Versus Zopiclone 7.5 mg - for the Treatment of Insomnia

Eszo
Start date: March 2011
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to determine whether eszopiclone (Eurofarma) is non-inferior to the reference drug zopiclone (Imovane®, Sanofi-Aventis) in the treatment of insomnia.

NCT ID: NCT01099579 Completed - HIV Infections Clinical Trials

PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)

PRINCE1
Start date: October 13, 2010
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether atazanavir powder combined with ritonavir is safe and well tolerated and produces appropriate drug exposure in children ≥3 months to <6 years of age.

NCT ID: NCT01098539 Completed - Clinical trials for Diabetes Mellitus, Type 2

A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.

Start date: May 2010
Phase: Phase 3
Study type: Interventional

This randomized, double-blind, active-controlled study evaluates the efficacy and safety of a weekly dose of albiglutide as compared with sitagliptin. Subjects who are renally impaired with a historical diagnosis of type 2 diabetes mellitus and whose glycemia is inadequately controlled on their current regimen of diet and exercise or their antidiabetic therapy of metformin, thiazolidinedione, sulfonylurea, or any combination of these oral antidiabetic medications will be recruited into the study.

NCT ID: NCT01097161 Completed - Stuttering Clinical Trials

Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program

SAS:EIP
Start date: April 2007
Phase: N/A
Study type: Interventional

Subjects' utterances were submitted to acoustic analysis before and after the intervention program applied on prosodic basis.

NCT ID: NCT01097031 Completed - Blood Pressure Clinical Trials

Continuous or Intermittent for Keeping Arterial Catheter in Children: A Randomized Clinical Trial

UP4061
Start date: October 2007
Phase: N/A
Study type: Observational

Randomized Clinical Trial to evaluate which is the best infusion system of heparin solution for Keeping the mean invasive blood pressure whether the continuous system and the intermittent one.